A routine intervention given within hours of birth has protected American newborns from life-threatening bleeding since 1961. Now, more parents are refusing it, and researchers say the consequences are beginning to show up in infant mortality data in ways that are deeply alarming.
New investigative findings and a separate peer-reviewed study both point to a meaningful and accelerating decline in the rate at which newborns are receiving vitamin K injections at birth. The trend appears to be tied to broader currents of medical skepticism that have intensified in recent years, and health experts say the stakes could not be higher.
Why vitamin K matters at birth
Every baby is born deficient in vitamin K, a nutrient essential to blood clotting. Without it, newborns cannot produce the clotting factors their bodies need to stop bleeding naturally. A single injection given within six hours of birth corrects that deficiency and protects against what is known as vitamin K deficiency bleeding, a condition that can cause severe hemorrhaging in the brain and gastrointestinal tract.
The risk window extends through the first six months of life. Normal nutrition for newborns, including breast milk, does not provide enough vitamin K to compensate for this early deficiency. Infants who do not receive the shot are estimated to be more than 80 times more likely to experience vitamin K deficiency bleeding, which carries a mortality rate of roughly one in five.
Because the bleeding often occurs internally, particularly in the brain, parents may have no visible indication that anything is wrong until the situation becomes a medical emergency. That delayed recognition can make the difference between survival and death.
The refusal rate is climbing sharply
Analysis of electronic medical records from more than 5 million births across over 40 hospitals in all 50 states between 2017 and 2024 found that the share of infants not receiving the vitamin K shot at birth nearly doubled over that period, rising from just under 3 percent to more than 5 percent. The sharpest increase occurred after 2020, though the shift was already underway before the pandemic began, suggesting that medical skepticism tied to the pandemic is not the only driver.
Investigative reporting examining federal and state death certificate data estimated that a meaningful portion of roughly 700 infant deaths involving spontaneous brain bleeding in 2024 were likely attributable to vitamin K deficiency. The total number of deaths directly linked to the deficiency remains relatively small, but the trajectory is moving in the wrong direction.
What is driving the refusal trend
Parents who decline the shot most often cite concerns about injection pain, doubts about whether the intervention is truly necessary, worry about preservatives in the formulation, and broader skepticism toward medical interventions at birth. Some parents operate under the mistaken belief that the shot is a vaccine and apply vaccine hesitancy reasoning to their decision. Others are drawn to the idea of a more natural birth experience with fewer medical interventions.
A long-debunked 1990 study falsely linking vitamin K to childhood cancer continues to circulate in certain online communities and has contributed to misinformation that persists decades after the research was thoroughly refuted. Births occurring outside hospital settings and without physician oversight are associated with higher rates of refusal, as are the influence of friends, social media figures, and in some cases alternative health practitioners.
The vitamin K shot has also been caught in the broader wave of declining confidence in standard childhood medical interventions, a trend that has affected uptake of established vaccines for measles and whooping cough as well. Vitamin K is one of three interventions recommended for newborns at birth by major pediatric health authorities, alongside a hepatitis B vaccine and an antibiotic eye treatment.
What experts want parents to understand
The medical consensus on vitamin K is not a matter of ongoing scientific debate. Decades of data show clearly that widespread use of the shot dramatically reduced infant deaths from vitamin K deficiency bleeding across the United States. The sharp decline in those deaths following the introduction of the standard practice in 1961 is considered one of the clearest success stories in neonatal medicine.
Experts warn that the very success of the intervention may be part of what is working against it now. When a medical problem becomes rare because prevention is effective, younger generations of parents have no lived experience of the consequences that used to follow from not acting. That absence of visible risk makes refusal feel lower-stakes than it actually is.
Vitamin K deficiency bleeding is almost entirely preventable. For a condition with a 20 percent mortality rate and a simple, safe, well-established solution, the cost of declining the shot is one that no family should have to absorb.
